Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Bio-Rad Laboratories, Inc. (BIO)'s share was trading at $323.69 as of Nov 20 th . BIO's forward P/E was 28.49 according to Yahoo Finance. A research laboratory showing advanced diagnostic equipment used to protect public health. Bio-Rad Laboratories (BIO) is a leading manufacturer and developer of laboratory equipment and biological testing solutions, with a robust global footprint and diversified revenue streams. The United States accounts for 42% of its revenue, followed by Europe at 31%, Asia at 21%, and other regions at 6%. Its customer base spans hospital labs (34% of revenue), reference labs (11%), transfusion labs (10%), academic and government institutions (21%), biopharma (15%), and applied markets (9%). This diversity ensures stability and resilience across economic cycles. The company benefits from a solid financial profile, characterized by rising operating margins and high levels of recurring revenue. Notably, Bio-Rad derives 80% of its sales from products in which it
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
- Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts, Strategies, Trends, Forecasts with Executive Guides [Yahoo! Finance]Yahoo! Finance
- The Global Market for Mouse Organoid Culture Mediums, 2025-2030: Discover Trends and Regional Growth Projections for Disease Modeling, Drug Screening, Regenerative Medicine, and Toxicology Study Applications [Yahoo! Finance]Yahoo! Finance
- Liquid Biopsy Market Size to Worth USD 28.84 Billion by 2033 | Straits Research [Yahoo! Finance]Yahoo! Finance
- Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare ConferenceBusiness Wire
BIO
Earnings
- 10/30/24 - Beat
BIO
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form SC
- 11/8/24 - Form SC
- BIO's page on the SEC website